These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7569545)

  • 41. [Comparative antigenic activity of the hepatitis A inactivated vaccine among military personnel].
    Shumilov VI; Shevtsov VA; Lobastov SP; Salmina TA; Shervarli VI; Vardanian NV; Nikolaeva EI
    Voen Med Zh; 2004 Jan; 325(1):62-5. PubMed ID: 15038272
    [No Abstract]   [Full Text] [Related]  

  • 42. Duration of protection from clinical hepatitis A disease after vaccination with VAQTA.
    Wiens BL; Bohidar NR; Pigeon JG; Egan J; Hurni W; Brown L; Kuter BJ; Nalin DR
    J Med Virol; 1996 Jul; 49(3):235-41. PubMed ID: 8818971
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatitis A: the vaccine dividend.
    Dienstag JL
    J Infect Dis; 2008 May; 197(9):1220-2. PubMed ID: 18422432
    [No Abstract]   [Full Text] [Related]  

  • 44. Immunization against hepatitis A during an outbreak in a Jewish Orthodox community--Quebec, 1997-1998.
    Deshaies D; Dion R; Valiquette L; Auger N
    Can Commun Dis Rep; 1998 Sep; 24(18):145-51. PubMed ID: 9780447
    [No Abstract]   [Full Text] [Related]  

  • 45. Safety and effectiveness of the new inactivated hepatitis A virus vaccine.
    Furesz J; Scheifele DW; Palkonyay L
    CMAJ; 1995 Feb; 152(3):343-8. PubMed ID: 7828098
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vaccine for hepatitis A safe for HIV patients.
    Expert Rev Vaccines; 2004 Dec; 3(6):625-8. PubMed ID: 15606344
    [No Abstract]   [Full Text] [Related]  

  • 47. New combined hepatitis A and B vaccine. Risks Of viral hepatitis related to travel.
    Zuckerman JN
    BMJ; 1998 Apr; 316(7140):1317. PubMed ID: 9554910
    [No Abstract]   [Full Text] [Related]  

  • 48. Prevention of hepatitis A.
    Gardner P
    Am J Med; 1998 Nov; 105(5):452-3. PubMed ID: 9831431
    [No Abstract]   [Full Text] [Related]  

  • 49. Hepatitis A vaccine.
    Nalin DR
    J Occup Environ Med; 1996 Dec; 38(12):1200-1. PubMed ID: 8978510
    [No Abstract]   [Full Text] [Related]  

  • 50. New combined hepatitis A and B vaccine. New vaccine is an adjunct, not an alternative to preventive behaviours.
    Birthistle K; Benbow A
    BMJ; 1998 Apr; 316(7140):1317-8. PubMed ID: 9599053
    [No Abstract]   [Full Text] [Related]  

  • 51. [Hepatitis A vaccine].
    Ring-Larsen H
    Ugeskr Laeger; 1995 Dec; 157(50):7024-7. PubMed ID: 8545925
    [No Abstract]   [Full Text] [Related]  

  • 52. Hepatitis A vaccine gains marketing approval.
    Am J Health Syst Pharm; 1995 May; 52(9):926, 931. PubMed ID: 7641029
    [No Abstract]   [Full Text] [Related]  

  • 53. Clinical trial to evaluate immunogenicity and safety of inactivated hepatitis A vaccination starting at 2-month-old children.
    Kanra G; Yalçin SS; Ceyhan M; Yurdakök K
    Turk J Pediatr; 2000; 42(2):105-8. PubMed ID: 10936974
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Study on the immunogenicity and safety of 2 kinds of inactivated hepatitis A vaccine vaccinated in 1-3 years old children].
    Fu Y; Li ZL; Lao SJ; Wang M; Chen QB; Chen SJ; Li JG; Zhang Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):551-2. PubMed ID: 15231151
    [No Abstract]   [Full Text] [Related]  

  • 55. [Comparison of immunology effects between live attenuated hepatitis A vaccine and inactivated hepatitis A vaccine].
    Wang X; Meng Z; Li R
    Zhonghua Yi Xue Za Zhi; 2000 Jun; 80(6):422-4. PubMed ID: 11798797
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatitis A vaccine.
    Cleghorn G
    Qld Nurse; 1995; 14(3):11. PubMed ID: 7568977
    [No Abstract]   [Full Text] [Related]  

  • 57. Protection of travelers against Hepatitis A viral infection in developing countries.
    Arya SC
    J Travel Med; 1998 Dec; 5(4):228-9. PubMed ID: 9935325
    [No Abstract]   [Full Text] [Related]  

  • 58. Travel prophylaxis. Assumptions were confusing.
    Van Damme P; Van Doorslaer E; Tormans G; Beutels P
    BMJ; 1995 Feb; 310(6976):402. PubMed ID: 7866237
    [No Abstract]   [Full Text] [Related]  

  • 59. Inactivated hepatitis A vaccine.
    Wkly Epidemiol Rec; 1992 Aug; 67(35):261-3. PubMed ID: 1390039
    [No Abstract]   [Full Text] [Related]  

  • 60. Anatomy of a trial: a historical view of the Monroe inactivated hepatitis A protective efficacy trial.
    Werzberger A; Kuter B; Shouval D; Mensch B; Brown L; Wiens B; Lewis J; Miller W; Sitrin R; Provost P
    J Hepatol; 1993; 18 Suppl 2():S46-50. PubMed ID: 8182273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.